These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 25164707)
1. Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches? Killoran A; Biglan KM Mov Disord; 2014 Sep; 29(11):1404-13. PubMed ID: 25164707 [TBL] [Abstract][Full Text] [Related]
2. The current clinical management of Huntington's disease. Phillips W; Shannon KM; Barker RA Mov Disord; 2008 Aug; 23(11):1491-504. PubMed ID: 18581443 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic approaches to the treatment of Huntington's disease. Venuto CS; McGarry A; Ma Q; Kieburtz K Mov Disord; 2012 Jan; 27(1):31-41. PubMed ID: 21997232 [TBL] [Abstract][Full Text] [Related]
7. Management and outcome of pallidal deep brain stimulation in severe Huntington's disease. Huys D; Bartsch C; Poppe P; Lenartz D; Huff W; Prütting J; Timmermann L; Klosterkötter J; Maarouf M; Rommel T; Hartmann A; Sturm V; Kuhn J Fortschr Neurol Psychiatr; 2013 Apr; 81(4):202-5. PubMed ID: 23589113 [TBL] [Abstract][Full Text] [Related]
8. [Huntington chorea. Clinical correlations and preliminary neuropsychological data]. Fragassi NA; Stanzione M; Angelini R; Di Maio L Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994 [TBL] [Abstract][Full Text] [Related]
9. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease. de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067 [TBL] [Abstract][Full Text] [Related]